相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体英文名:
Phospho-PKC (pan) (βII Ser660) Antibody
- 抗原:
synthetic phosphopeptide corresponding to residues surrounding Ser660 of human PKC β II
- 应用范围:
W
- 宿主:
Rabbit
- 适应物种:
H,M,R,Mk
- 库存:
大量
- 保质期:
详见说明书
- 级别:
详见MSDS文件
- 供应商:
CST
- 是否单克隆:
2
- 保存条件:
-20°c
- 规格:
40 ul (4 western blots)/100 ul (10 western blots)/carrier free & custom formulation / quantity
| 规格: | 产品价格: | ¥请询价 | |
|---|---|---|---|
| 规格: | 40 ul (4 western blots) | 产品价格: | ¥请询价 |
| 规格: | 100 ul (10 western blots) | 产品价格: | ¥请询价 |
| 规格: | carrier free & custom formulation / quantity | 产品价格: | ¥请询价 |
pathway more info application references datasheet PDF MSDS PDF protocols
Applications Key: W=Western Blotting
Reactivity Key: H=Human M=Mouse R=Rat Mk=Monkey
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.
| Applications | Reactivity | Sensitivity | MW (kDa) | Source |
|---|---|---|---|---|
| W | H M R Mk | Endogenous | 78, 80, 82, 85 | Rabbit |
| Protocols |
|
|---|---|
| Specificity / Sensitivity | Phospho-PKC (pan) (βII Ser660) Antibody detects endogenous levels of PKC α, β I, β II, δ, ε, η and θ isoforms only when phosphorylated at a carboxy-terminal residue homologous to serine 660 of PKC β II. This antibody does not detect PKC phosphorylated at other sites. |
| Source / Purification | Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Ser660 of human PKC β II. Antibodies are purified by protein A and peptide affinity chromatography. Western Blotting
Western blot analysis of Baculovirus expressed PKCβ and PKCβ Ser660/Ala mutant, using Phospho-PKC (pan) (βII Ser660) Antibody (upper) or control PKCβ antibody (lower). Western Blotting
Western blot analysis of extracts from TPA, Go6983 and/or Bisindolylmaleimide treated 293 cells, using Phospho-PKC (pan) (βII Ser660) Antibody. Western Blotting
Western blot analysis of Baculovirus expressed PKC isoforms, using Phospho-PKC (pan) (βII Ser660) Antibody. |
| Background | Activation of protein kinase C (PKC) is one of the earliest events in a cascade that controls a variety of cellular responses, including secretion, gene expression, proliferation, and muscle contraction (1,2). PKC isoforms belong to three groups based on calcium dependency and activators. Classical PKCs are calcium-dependent via their C2 domains and are activated by phosphatidylserine (PS), diacylglycerol (DAG), and phorbol esters (TPA, PMA) through their cysteine-rich C1 domains. Both novel and atypical PKCs are calcium-independent, but only novel PKCs are activated by PS, DAG, and phorbol esters (3-5). Members of these three PKC groups contain a pseudo-substrate or autoinhibitory domain that binds to substrate-binding sites in the catalytic domain to prevent activation in the absence of cofactors or activators. Control of PKC activity is regulated through three distinct phosphorylation events. Phosphorylation at Thr500 in the activation loop, the autophosphorylation site at Thr641, and at carboxy-terminal hydrophobic site Ser660 occurs in vivo (2). Atypical PKC isoforms lack hydrophobic region phosphorylation, which correlates with the presence of glutamic acid rather than the serine or threonine residues found in more typical PKC isoforms. Either the enzyme PDK1 or a close relative is responsible for PKC activation. A recent addition to the PKC superfamily is PKCμ (PKD), which is regulated by DAG and TPA through its C1 domain. PKD is distinguished by the presence of a PH domain and by its unique substrate recognition and Golgi localization (6). PKC-related kinases (PRK) lack the C1 domain and do not respond to DAG or phorbol esters. Phosphatidylinositol lipids activate PRKs and small Rho-family GTPases bind to the homology region 1 (HR1) to regulate PRK kinase activity (7).
|
| Application References |
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know ! |
| Companion Products |
For Research Use Only. Not For Use In Diagnostic Procedures. |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验dxs_jhr 想做关于该课题的,请问哪位高人能够提供PKCβII是否在肝和肠组织有所表达,正常的生理情况下是否存在?非常感谢中 licanming 建议查一下文献,我这里提供一张图给你参考: dxs_jhr 谢谢了,这个表我已经看见过,但是和您的有些出入,βI的表达好像是少数组织 licanming 表我是在一篇文献上截下来的。文献我挂上来
提示我模型中的通路究竟涉及哪个亚型,而我又没有那么多经费一个一个亚型去试,故我想能不能就检测总的PKC激活水平,毕竟有亚型被激活,那总的活化PKC水平也应该会升高啊!虽然敏感性和特异性肯定没有单独检测一个亚型的高。 还想请教:Phospho-PKC (pan) (gamma Thr514) Antibody 和Phospho-PKC (pan) (βII Ser660) Antibody 这两个抗体的针对的亚型有什么不同?既然都是pan,那是否说都是针对所有的亚型,只是磷酸化的残基不同
PKC系统(protein kinase C system,PKC system)
由于该系统中的第二信使是磷脂肌醇,故此这一系统又称为磷脂肌醇信号途径(phosphatidylinositol signal pathway)。 在这一信号转导途径中,膜受体与其相应的第一信使分子结合后,激活膜上的Gq蛋白(一种G蛋白),然后由Gq蛋白激活磷酸脂酶Cβ (phospholipase Cβ, PLC), 将膜上的脂酰肌醇4,5-二磷酸(phosphatidylinositol biphosphate, PIP2)分解为两个细胞内的第二信使:二酰甘油
技术资料暂无技术资料 索取技术资料








